The strongest angle for this story is that a new fiber blend showed promising gut-microbiome changes without worsening IBS symptoms. One important qualification: the trial was small and short, and it did not prove that the supplement relieves IBS pain or other symptoms. The article below keeps that distinction clear while highlighting why the findings matter.
Here is a publish-ready news article with an engaging headline, SEO details, FAQs and careful reporting on what the research does—and does not—prove.
New IBS Fiber Supplement Could Help Improve Gut Health Without Triggering Pain or Bloating
A newly studied fiber supplement could offer hope to millions of people living with irritable bowel syndrome (IBS). Researchers at Edith Cowan University (ECU) in Australia found that a specially formulated fiber blend improved the composition of gut bacteria and reduced gut-related anxiety without worsening common digestive symptoms.
The supplement, known as ur gut®, combines resistant starch with psyllium husk. The researchers believe this combination could help people following a low-FODMAP diet increase their fiber intake while supporting a healthier gut microbiome.
The findings are attracting attention because many people with IBS struggle to consume enough fiber. Some high-fiber foods can trigger gas, bloating and abdominal discomfort, making dietary management particularly difficult.
However, the results need to be interpreted carefully. The study involved only 26 participants and lasted three weeks. It showed that the supplement was tolerated without worsening symptoms and changed gut bacteria, but it did not establish that the product cures IBS or directly reduces abdominal pain.
New Fiber Supplement Offers Hope for People With IBS
The research team from ECU’s Nutrition and Health Innovation Research Institute investigated whether a targeted fiber combination could improve gut health in people already following a low-FODMAP diet.
IBS is a common digestive disorder associated with abdominal pain, bloating, diarrhea, constipation or changes in bowel habits. Symptoms can vary considerably between individuals, and some people experience periods of improvement followed by uncomfortable flare-ups.
According to the researchers, dietary restrictions can help people control symptoms, but they may also reduce the amount of fiber they consume. This creates a challenge because dietary fiber supports beneficial gut bacteria and normal digestive function.
The ur gut® formulation was developed to address that challenge. Instead of relying on a single type of fiber, it combines resistant starch and psyllium husk in a specific formulation.
Researchers reported that participants who received the supplement experienced changes in their gut microbiome while their IBS symptoms remained stable. The findings suggest that improving gut health may be possible without necessarily making digestive discomfort worse.
Why Traditional IBS Diets Can Create a Fiber Challenge
A low-FODMAP diet is commonly used to help manage IBS symptoms. FODMAP stands for fermentable oligosaccharides, disaccharides, monosaccharides and polyols.
These are types of short-chain carbohydrates found in a variety of foods. Some people with IBS have difficulty tolerating them because they can be poorly absorbed in the small intestine and rapidly fermented by gut bacteria.
This fermentation can increase gas production and draw water into the intestine. For people with heightened digestive sensitivity, these changes may contribute to bloating, abdominal discomfort and altered bowel habits.
A low-FODMAP diet reduces certain foods containing these carbohydrates. It can provide meaningful symptom relief for some people, but long-term restriction may also affect the gut microbiome and reduce dietary fiber intake.
That matters because gut bacteria use certain types of fiber as fuel. Their fermentation produces compounds called short-chain fatty acids, which play important roles in intestinal health.
The ECU researchers wanted to investigate whether people could maintain symptom control while adding a carefully selected fiber source to their diets.
Their findings point toward a possible strategy, although more research is needed before the approach can be considered a proven treatment.
How Resistant Starch and Psyllium Husk Work Together
The ur gut® supplement combines two types of fiber: resistant starch and psyllium husk.
Resistant starch is a type of carbohydrate that resists digestion in the small intestine. Instead of being broken down and absorbed like ordinary starch, it travels into the large intestine, where gut bacteria can ferment it.
This fermentation can support beneficial microorganisms and produce short-chain fatty acids. These substances are involved in several processes linked to intestinal health.
However, resistant starch can be difficult for some people with IBS to tolerate. Its fermentation may produce gas, potentially increasing bloating and discomfort.
Psyllium husk is a soluble fiber that absorbs water and forms a gel-like substance in the digestive system. It is commonly used in fiber supplements and can help regulate bowel movements.
The ECU researchers proposed that combining psyllium with resistant starch could change how the resistant starch is fermented. Their explanation is that psyllium may delay fermentation, allowing more resistant starch to reach deeper sections of the colon.
This approach could potentially provide benefits associated with fermentation while improving tolerance among people with sensitive digestive systems.
What the Clinical Trial Discovered
The study was published online on September 24, 2026, in the European Journal of Nutrition. It was designed as a randomized, double-blind controlled trial.
A total of 26 adults with IBS completed the research. Participants were already following a low-FODMAP diet and were randomly assigned to receive either ur gut® or a comparison supplement for three weeks.
The two groups included 13 participants each. The comparison supplement contained psyllium husk but did not include the resistant starch used in the ur gut® formulation.
Participants gradually increased their daily intake from 5 grams to 40 grams over 11 days. They then continued at the full dose for another 10 days.
Researchers monitored digestive symptoms, dietary intake, gut bacteria, sleep patterns and other health measures.
The findings included several important observations:
- Participants receiving ur gut® showed significant changes in the overall composition of their gut microbiota.
- The abundance of a bacterial group identified as Ruminococcus E increased approximately 5.5-fold in the supplement group.
- Participants reported improvements in gastrointestinal-specific anxiety.
- IBS symptoms remained stable during the intervention rather than becoming worse.
- Researchers did not find significant changes in the measured blood and stool biomarkers.
These results suggest that the fiber blend may influence gut bacteria while remaining tolerable for people with IBS who follow a low-FODMAP diet.
Gut Bacteria and Digestive Anxiety May Be Connected
One particularly interesting finding involved gastrointestinal-specific anxiety.
People living with IBS can experience anxiety connected to their digestive symptoms. They may worry about sudden abdominal pain, bloating or the need to find a bathroom while working, traveling or attending social events.
These concerns can affect daily routines and quality of life.
The researchers found that participants taking ur gut® reported an improvement in gut-related anxiety after the intervention. The study also identified an improvement in one quality-of-life measure.
Scientists are increasingly investigating the relationship between the gut microbiome and the brain. This communication network is commonly described as the gut-brain axis.
Gut bacteria can produce substances that interact with processes involved in intestinal function and nervous-system signaling. Researchers are studying whether changes in the microbiome could influence mood, stress responses and digestive sensitivity.
However, the ECU trial does not establish that the supplement directly treats anxiety or mental health conditions. Its findings provide an early indication that changes in gut bacteria and digestive-related well-being may be connected.
The researchers will need larger studies to determine whether these improvements can be reproduced and maintained over longer periods.
Why the Results Need More Research
Although the findings are encouraging, the study has important limitations.
First, only 26 participants completed the trial. A study of this size can provide useful early evidence, but it cannot establish whether the supplement will work for the wider IBS population.
Second, the intervention lasted just three weeks. Researchers do not yet know whether the observed changes in gut bacteria will continue over several months or whether participants will experience similar results with long-term use.
The study also did not demonstrate a reduction in the severity of IBS symptoms. Instead, symptoms remained stable while the gut microbiome changed.
That distinction is important. A supplement that does not worsen digestive symptoms may be useful, but it is not automatically a treatment that relieves existing pain, diarrhea or constipation.
Researchers also reported no significant changes in the measured blood and stool biomarkers. This means the microbiome findings should not be interpreted as proof that the supplement improved every aspect of intestinal health.
Another consideration is that the research was conducted by scientists affiliated with Edith Cowan University, which owns the ur gut® trademark. The formula is also the subject of an international patent application.
These details do not invalidate the findings, but independent research would help strengthen confidence in the results.
What the Findings Could Mean for Future IBS Treatment
The study could help encourage a broader approach to managing irritable bowel syndrome.
For many people, IBS management focuses heavily on identifying foods that trigger symptoms and reducing their consumption. While dietary changes can be helpful, avoiding too many foods may make it harder to maintain a balanced diet with adequate fiber.
A targeted fiber supplement could eventually provide another option for people who need to manage symptoms while supporting their gut microbiome.
The ur gut® findings are particularly relevant to people following a low-FODMAP diet. The researchers suggest that the formulation may help address concerns about fiber intake and changes in gut bacteria associated with restrictive eating patterns.
The university has also reported that the supplement is available for purchase and that researchers have developed a cookbook to help people incorporate it into a healthy diet.
Nevertheless, availability should not be confused with established medical effectiveness. The current evidence is preliminary, and the product has not been proven to work for every person with IBS.
People considering a new fiber supplement should discuss it with a qualified healthcare professional, particularly if they have significant digestive symptoms, other gastrointestinal conditions or dietary restrictions.
The Bottom Line: A Promising Development, Not Yet an IBS Cure
The new ECU research offers an encouraging development in the search for better ways to support gut health in people with irritable bowel syndrome.
The combination of resistant starch and psyllium husk changed the composition of gut bacteria and improved gastrointestinal-specific anxiety in a small controlled trial. Importantly, participants did not experience worsening IBS symptoms during the intervention.
The results could help researchers develop dietary strategies that support the gut microbiome without sacrificing symptom control.
However, the trial does not prove that ur gut® relieves IBS pain or provides a long-term solution. Larger and longer studies are needed to establish its safety, effectiveness and potential benefits across different IBS subtypes.
For now, the research offers a promising direction for future IBS treatment rather than a confirmed breakthrough that patients should expect to work immediately.
Frequently Asked Questions About the New IBS Fiber Supplement
What is the new fiber supplement for IBS?
The supplement is called ur gut®. It combines resistant starch and psyllium husk and was developed by researchers at Edith Cowan University to support gut health in people with IBS.
Can the ur gut® supplement cure irritable bowel syndrome?
No. The research does not show that the supplement cures IBS. It found changes in gut bacteria and improved gut-related anxiety without worsening digestive symptoms during a short trial.
Did the supplement reduce bloating and abdominal pain?
The study found that participants’ IBS symptoms remained stable. It did not demonstrate that the supplement directly reduced bloating, abdominal pain, diarrhea or constipation.
What ingredients are included in the fiber blend?
The formulation combines resistant starch with psyllium husk. Researchers believe psyllium may delay the fermentation of resistant starch, helping it reach deeper sections of the colon.
How many people participated in the study?
Twenty-six adults with IBS completed the randomized, double-blind controlled trial. Thirteen received ur gut® and 13 received the comparison supplement.
How long did the IBS fiber supplement trial last?
Participants received the supplement or comparison product for three weeks after a one-week baseline period.
Is the new fiber supplement suitable for everyone with IBS?
The study does not establish that it is suitable for everyone. People with IBS should consult a healthcare professional before starting a new supplement or making major dietary changes.
What happens next in IBS fiber research?
Larger and longer clinical studies are needed to determine whether the microbiome changes continue over time, whether symptoms improve in some patients and how the supplement compares with other dietary approaches.
Research source: Ran Yan and colleagues, “Dietary fibre blend improves gut health in patients with irritable bowel syndrome following a low FODMAP diet: a randomised, double-blind control trial,” published in the European Journal of Nutrition in September 2026.
References
- Edith Cowan University research announcement
- Published clinical trial – European Journal of Nutrition
- PubMed research record
Editorial note: The most accurate headline angle is that the supplement improved gut microbiome measures without worsening symptoms—not that it has been proven to relieve or cure IBS.